Overview
Ahmed Alnatsha practices in Munich, Germany. Mr. Alnatsha is rated as an Experienced expert by MediFind in the treatment of Xeroderma Pigmentosum. His top areas of expertise are Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Xeroderma Pigmentosum, and Non-Small Cell Lung Cancer (NSCLC).
His clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Xeroderma Pigmentosum.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung CancerMr. Alnatsha isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Alnatsha isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pancreatic CancerMr. Alnatsha isExperienced. Learn about Pancreatic Cancer.
- Pancreatic Ductal AdenocarcinomaMr. Alnatsha isExperienced. Learn about Pancreatic Ductal Adenocarcinoma.
- Xeroderma PigmentosumMr. Alnatsha isExperienced. Learn about Xeroderma Pigmentosum.